Dr. Graham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 North 4th Street
Springfield, IL 62794Phone+1 217-757-8100Fax+1 217-747-1351
Summary
- Dr. David Graham is a family physician in Springfield, IL and is affiliated with multiple hospitals in the area, including Memorial Medical Center and HSHS St. John's Hospital. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice 22 years. He specializes in obstetrics and is experienced in health technology/informatics.
Education & Training
- Oregon Health & Science University (OHSU Health)Chief Residency, Family Medicine, 1998 - 1999
- University of Washington School of MedicineFaculty Development - Family Medicine, 1998 - 1999
- Oregon Health & Science University (OHSU Health)Residency, Family Medicine, 1996 - 1998
- Oregon Health & Science University (OHSU Health)Internship, Family Medicine, 1995 - 1996
- Northwestern University The Feinberg School of MedicineClass of 1995
Certifications & Licensure
- CO State Medical License 2004 - 2025
- OR State Medical License 1998 - 2025
- IL State Medical License 2007 - 2023
- American Board of Preventive Medicine Clinical Informatics
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Clinical Trials
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma Start of enrollment: 2011 Feb 09
- Join now to see all
Press Mentions
- Hospital Patient Safety RatingsNovember 18th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: